诊疗指南

2016 ASCO临床实践指南:女性早期浸润性乳腺癌患者使用生物标志物指导辅助性全身治疗

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women with Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.
2016-02-19 21:57 点击次数:444发表评论

This guideline provides evidence-based recommendations to practicing oncologists and other stakeholders on the appropriate use of breast tumor biomarker assay results to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer with known hormone receptor (estrogen and progesterone receptors [ER/PgRs]) and human epidermal growth factor receptor 2 [HER2]) status. In an era of great interest in personalized, precision medicine, the role of tumor biomarker assays in guiding clinical care has taken on even greater importance than in the past.

    
学科代码:肿瘤学   关键词:女性 早期浸润性乳腺癌 生物标志物 ,指南 爱思唯尔医学网, Elseviermed
顶一下(0
您可能感兴趣的指南
    发表评论网友评论(0)
      发表评论
      登录后方可发表评论,点击此处登录